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ABSTRACT 
 
Muscular Dystrophy (MD) results in muscle atrophy, loss of ambulation and reduced physical 
activity through chronic inflammation leading to muscle damage and derangement of muscle 
physiology. Reduced physical activity relating to muscle weakness and reduced muscle 
anatomical cross-sectional area (ASCA) due to atrophy lead to a reduction in tensile and 
compression strain required to maintain bone mineral density (BMD), resulting in adverse 
bone health. Studies have demonstrated reductions in BMD and muscle size, primarily in 
children with Duchenne Muscular Dystrophy (DMD) – a severe variant – however there is no 
extant data describing muscle size in adults with MD, and data describing BMD in adults with 
other variants of MD is sparse (e.g. Becker‟s (BeMD), Limb Girdle (LGMD), and 
Fascioscapluohumeral dystrophy (FSHD)). The aim of this study was to measure BMD, 
tibialis anterior (TA) muscle ASCA, grip strength and physical activity in adult male individuals 
with four distinct variants of MD compared to unaffected adult male controls. TA ASCA was 
measured via B-mode ultrasound; BMD was measured using speed-of-sound ultrasound of 
midshaft Tibia (MST) and distal Radius (DR). Grip strength was assessed through isometric 
dynamometer contraction; and physical activity through use of two questionnaires. 40 adult 
males with MD and 10 unaffected male controls were measured for demographic information, 
T- & Z-scores of BMD, TA ASCA, maximum grip strength and physical activity. BMD 
assessed by Z-score was lower in DMD individuals compared to all other participants in tibia 
and radius and lower in BeMD and FSHD individuals compared to CTRL (P<0.05). There was 
no difference in T or Z scores between CTRL and LGMD participants. TA ASCA was smaller 
in all MD individuals compared to controls (BeMD -39.7%; DMD -59.7%; FSHD -58.9%; 
LGMD -62.4%) (P<0.05). Physical activity was lower in DMD individuals compared with all 
other MD individuals (assessed by the Bone-specific Physical Activity Questionnaire) 
(P<0.05) and all MD groups demonstrated significant reductions in grip strength compared to 
control (BeMD -51.2%; FSHD -46.3%; LGMD -49.9%) (P<0.05). In conclusion, decreased TA 
ASCA was observed in all MD individuals and reduced T and Z scores observed in three of 
four groups compared to controls. MD individuals demonstrated reduced physical activity and 
grip strength compared to controls. Due to the link between BMD and physical activity it is 
recommended that efforts be made to encourage weight bearing activity and exercise in 
individuals with MD and that future research investigate the specific benefits of physical 
exercise in MD individuals to establish best practice for healthcare professionals.  
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CHAPTER 1- INTRODUCTION AND 
LITERATURE REVIEW 
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Introduction 
The Muscular Dystrophy Campaign (MDC) estimates that there are over 70,000 individuals in 
the UK affected by Muscular Dystrophy (MD) and related neuromuscular conditions 
(www.muscular-dystrophy.org). These conditions vary in severity but often lead to significant 
disability; loss of ambulation (Sussman, 2002), function and independence (Yamaguchi & 
Suzuki, 2013); and respiratory as well as cardiac complications (Ishikawa et al, 2011) in those 
affected with some severe variants which are life limiting. These individuals also pose a 
challenging issue in their medical and non-pharmacological management. Research is 
currently ongoing into genetic and pharmacological management however with an estimated 
8,000 individuals affected by neuromuscular conditions in the North-West of England alone 
(Bell, 2010), there is a need for quantitative investigation into the non-pharmacological 
management of these individuals to maximise quality of life and independence. The 
subsequent review will address the extant literature for functional, skeletal and muscular 
impairments in a range of muscular dystrophies; these dystrophies represent the most severe 
form - Duchenne MD (representing a clinical condition resulting in loss of life by the third 
decade), to milder forms of the condition such as Facioscapulohumeral Muscular Dystrophy 
(FSHD), where individuals present later in life and can maintain ambulation throughout their 
lifespan. 
 
Aetiology 
There is well-established molecular and genetic data describing the biochemical defects in 
human muscle in individuals with MD. Hoffman et al (1987) described the mechanism of 
weakness and functional loss in Duchenne Muscular Dystrophy (DMD) – the most severe and 
disabling form – with preliminary work into exon deletion carried out by Monaco et al (1985). 
Similarly, biological data for Becker Muscular Dystrophy (BeMD) undertaken during the same 
decade indicated the two diseases share a common genetic origin – the defective coding of 
the muscular cytoskeleton membrane protein Dystrophin. The resultant absence or mutation 
of Dystrophin in human muscle leads to reduced cohesion of muscle fibres during whole 
muscle contraction and a subsequent „shearing‟ effect within individual fibrils – the so-called 
„membrane hypothesis‟ (Hutter, 1992). An absence of Dystrophin has more recently been 
demonstrated to cause aberrant regulation of membrane Nitric Oxide synthesis. Nitric Oxide 
is normally generated through membrane shear force and causes intramuscular vasodilation 
– improving blood supply and reducing ischaemic damage to contracting muscle tissue 
(Brenman et al, 1995). Over years of repeated contraction this manifests as a low-level 
inflammatory response, with biochemical markers of muscle degeneration (such as Plasma 
DNA Fragmentation) significantly elevated and markers of muscle regeneration (such as 
Vascular Endothelial Growth Factor – VEGF) significantly reduced in vitro compared to 
unaffected, age- and sex-matched controls (Abdel-Salam et al, 2009). Muscle tissue is 
subsequently destroyed; compromising function and force output (Villalta et al, 2014).  
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Pathophysiology of functional impairments 
Muscle atrophy and weakness in DMD individuals result in a clinical presentation of proximal 
muscle weakness resulting in reducing ambulation through childhood and wheelchair 
dependency by mid-teens, upper limb and distal muscle weakness occur as the condition 
progresses with age. A three-year study of 6-minute walk tests and North Star Ambulatory 
Assessments (a DMD specific 26-point motor function scale) of 96 paediatric DMD individuals 
(5-16 years, mean: 8.82), compiled by a collaboration of European hospitals, revealed 
significantly reduced scores on both measures at every point of measurement (12, 24, 36 
months) (Pane et al, 2014), demonstrating an accelerating decline in ambulatory function. 
Additionally, statistics compiled by the United States MDStar Net analysed in 2007 
demonstrate a wheelchair dependence of DMD individuals concurrent with the ambulation 
figures described above of 29, 82 and 90% for 5-9, 10-14 and 15-24 yr olds, respectively 
(CDC, 2007). 
 
Within DMD non-invasive ventilation support is usually required by the second decade – 
typically associated with a loss of ambulation and subsequent reduction in lung volume and 
respiratory muscle strength due to positioning and disuse (Bushby et al, 2010). Life 
expectancy, despite marked improvements owing to medical advances in the last two 
decades, is usually the third decade (Eagle et al 2002). Despite observations on clinical 
appearance there are no long-term studies of functional ambulatory performance in 
participants other than DMD individuals (Pane et al, 2014), despite well-established data 
indicating muscle weakness as a predictor of ambulatory function in other clinical populations. 
 
Although respiratory and skeletal muscle impairments are reported in children with DMD and 
associated with an absence of dystrophin, other dystrophic conditions present. A mutated 
version of healthy dystrophin is a cardinal feature of Becker Muscular Dystrophy (BeMD) – 
with individuals experiencing reduced muscle strength, loss of ambulation and cardiac 
involvement due to similar pathological origins, however with a reduced severity in clinical 
presentation. 
 
Cytoskeletal muscle protein defects are also responsible for proximal muscle weakness in 
Limb Girdle Muscular Dystrophy (LGMD). There are currently two gross types of LGMD with 
further subdivisions (LGMD Type 1A-H; LGMD Type 2A-Q) with each classification relating to 
a specific myoprotein genetic defect. For example, mutated Dysferlin – a protein involved in 
the regulation of muscle membrane repair – in LGMD Type 2B results in compromised 
sarcolemma regeneration in human muscle due to impaired calcium-mediated membrane 
repair and delayed myoblast fusion in response to muscle damage (Bushy and Laval, 2008). 
Subsequent accumulation of microtrauma and injury leads to reduced muscle tissue 
cohesion, (evidenced by fibre derangement and abnormality observed on biopsy) and a 
clinical presentation of weakness.   
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The pathogenesis of FSHD is less well understood. Research indicates that a defect on 
chromosome 4 – specifically a contraction of the D4Z4 subunit – was identified in all FSHD 
individuals (Lemmers et al, 2010). It is likely that this defect results in a mis- or 
overexpression of DUX4, a gene that when bound to specific human defensins inhibits 
muscle cell differentiation from stem cells, reduces innate immune response to virus invasion 
and encourages apoptotic cell death thereby leading to muscle atrophy and weakness. 
 
Atrophy and strength in muscular dystrophy 
Despite ongoing genetic, biomolecular and pharmacological research into these conditions 
there is a paucity of published evidence describing whole muscle structure and function in 
individuals affected by MD. Research undertaken in mice affected by a form of dystrophy 
(mdx) describes comparative muscle weakness when compared with unaffected controls as 
assessed by electrically-elicited isometric muscle contractions (Lynch et al, 2001). Lynch et al 
also describes an enlargement of certain limb muscles (particularly those involved in 
locomotion) compared to control mice. This 'pseudohypertrophy' (an apparent increase in 
tissue size without an increase in cell number), caused by infiltration of fibrous and adipose 
tissue into the muscle, secondary to an inflammatory response to microscopic muscle 
damage is described in mdx mice and is demonstrated in human DMD individuals in Fig 1.0 
(Wang et al, 2011).  
 
 
 
Fig 1.0 – A) Haemotoxylin and Eosin (HE) staining of control sample B) HE staining of 5-year-old DMD child  C) Snap 
frozen quadriceps tissue of control sample D) Snap frozen quadriceps tissue of 5-year-old DMD child. B) and D) - 
Evident fibre disorganisation, variable fibre size, intramuscular adipose/fibrous tissue infiltration and evidence 
aggregated muscle fibres attempting regeneration (Wang et al, 2011). 
10 
 
In humans, a comprehensive descriptive study undertaken by Jones et al (1983) analysed the 
composition of calf and quadriceps musculature as assessed by Computed Tomography (CT) 
and in biopsy samples, in 12 boys (7-18 years) affected by DMD. The study identifies at 
length the constitution of dystrophic muscle tissue compared to 5 healthy (though non-age 
matched) controls. Similar to MDX mice (Dellorusso et al 2001), Jones et al conclude that 
muscle enlargement in DMD is the result of accumulations of intramuscular fat and 
connective tissue (identified as increased intramuscular shadowing on X-ray) in the presence 
of relatively normal amounts of muscle tissue (Fig 1.1). This pseudohypertrophy, is further 
confirmed by circumferential calf measurements in DMD compared to a non-dystrophic group 
of age-matched boys (Ichiyama 1991). However it is impossible to distinguish between the 
muscular and non-muscular content using circumferential measures. 
 
 
Fig 1.1 Quadriceps (top) and Calf CT scans of control (left) and DMD individuals. Dark areas of CT indicate areas of 
less dense adipose infiltrates in muscle tissue. Gross Cross-sectional Area (ASCA) of calves is increased in DMD in 
presence of reduced muscle mass (Jones et al, 1983). 
 
Preceding the observation of dystrophic skeletal muscle tissue in mice carried out by Lynch 
(2001), De Bruin et al (1997) described diaphragm muscle thickness (as assessed by 
ultrasonography) compared to inspiratory strength (mouth pressure) in 10 human DMD 
participants (Aged 7-12 years, mean age 10.3years). Diaphragmatic thickness was 
significantly higher in DMD participants than Control (0.26mm, 14.9%) during diaphragm 
relaxation indicating a potential pseudohypertrophy similar to limb muscles. However, during 
inspiration the diaphragm of non-affected control groups became visibly larger, likely 
indicative of a stronger muscle contraction. There were markedly reduced inspiratory strength 
values in the participants with DMD. Although this study is limited by the sample size and 
single-pathology design, it nonetheless represents the only evidence to date describing a 
comparison between muscle size and strength in humans affected by muscular dystrophy.  
 
All current published data of muscle structure in humans with MD has focussed on DMD 
children or adolescents as participants (Table 1.0). To date, there is has been no investigation 
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of muscle area or architecture in FSHD, BeMD or LGMD, or DMD participants at later stages 
of life. It is possible that this discrepancy arises from a predominance of paediatric medical 
services available to individuals with DMD. DMD individuals present with symptoms earlier, 
with more marked impact upon function and health, and as such may attend specialist clinic 
environments (where participant recruitment is more likely) more often than individuals with 
other forms of MD. Furthermore, the complexity of managing individuals with DMD compared 
to other, less severe, forms of MD, results in availability of DMD sample populations for study 
compared to conditions where individuals are more disparate or access health services less 
regularly.  
 
Table 1.0 Summary of muscle size measurements in dystrophic populations (Both human & animal models) 
Author Dystrophy Population Methods Results 
Lynch et al 
2001 
Mdx Mice 6-, 17-, 24-, 28-
month old mdx and 
control mice 
EDL, soleus and gastrocnemius 
muscles (in vitro) measured as 
total muscle mass, cross-sectional 
area and force output 
Muscle mass of mdx mice was larger 
throughout life (17-22%) relative to control 
Muscle power was lower in mdx mice 
(~20%) at every stage of life 
Dellorusso 
et al 2001 
Mdx Mice 2-19 month old mdx 
and control mice 
Stretch of maximally activated TA 
muscle (40% strain relative to 
muscle fibre length) followed by 
isometric contraction 
Force deficits in injured muscle in mdx mice 
4-7 times more significant than control mice 
Jones et al 
1983 
DMD 12 DMD boys (7-18 
years) and 5 control 
Computed CT and needle biopsy 
mid-thigh and calf  
Gross Volume: 
DMD > Control (calf) 
DMD < Control (Quads) 
Fat-free mass DMD < Control (calf & quads) 
Ichiyama 
1991 
(abstract) 
DMD 7 DMD boys (3-5 
years) & 165 
controls (3-6 years) 
Circumference tape measurement 
of thigh, knee calf and ankle 
DMD > controls (calf circumference) 
DMD > controls (calf/knee ratio) 
De Bruin 
et al 1997 
DMD 10 DMD boys (7-12 
years)  
12 control boys (6-
12 years) 
B-mode U/S measurement of 
diaphragm thickness 
FEV1, FVC and PEF measured on 
spiro-bank 
Resting thickness of diaphragm increased in 
DMD (by mean 0.26mm) 
Reduced forced expiratory pressure and 
volume in DMD and reduced muscle 
contraction 
 
Physical activity and muscular dystrophy 
Immobilisation or significant reductions in physical activity (such as those associated with 
physical disability and dependence upon powered mobility aids) are known to reduce muscle 
mass and strength (Creditor, 1993). A study of step activity in DMD boys through 
computerised activity monitors identified significant reductions in overall physical activity; both 
medium and high step-rate activity; and reduced maximum heart rates in 16 ambulatory DMD 
individuals compared to sex-matched, age-matched, able-bodied controls (McDonald et al, 
2005). McDonald et al also demonstrated a significant correlation between overall step 
activity and knee extensor muscle strength in the DMD participants but not the able-bodied 
controls, indicating a possible causal link between muscle weakness and immobility. Bed rest 
studies indicate a loss of thigh muscle cross-sectional area of 14% following 6-weeks 
12 
 
enforced immobilisation when assessed by MRI (Berg et al, 1997), with immobilised muscle 
tissue characterised by substantial reductions in muscle protein synthesis (Wall et al, 2013), 
impaired oxygen absorption by muscle tissue and changes to connective tissue architecture 
(Williams & Goldspink, 1984). It is likely therefore that higher levels of sedentary behaviour, 
and/or immobilisation of lower limb muscle groups associated with frequent, long-term use of 
powered mobility aids in individuals affected by muscular dystrophy will contribute to 
differences in muscle mass between predominantly seated individuals and those remaining 
ambulant (allowing for marked variations between individuals of the same age and condition). 
To date there is no extant data from adult humans comparing muscle mass between 
dystrophic conditions, where the sarcopenic effect (i.e. muscle loss compared to healthy age-
matched counterparts) may be expected to be worse than that seen in children and 
adolescents, owing to the duration of low habitual physical activity.  
 
 
The role of the inflammatory response and muscle atrophy 
Chronic, low-level inflammation generated from repeated, abnormal repair and structural 
damage in MD is known to have deleterious effects on muscle health. Elevated levels of the 
regulatory cytokine Interleukin-6 (IL-6) has been demonstrated in disease states such as 
Chronic Obstructive Pulmonary Disease (COPD) and following muscle damage from 
excessive exercise (Bruunsgaard, 2005), with IL-6 believed to play a central role in muscle 
metabolism, satellite cell proliferation and suppression of macrophage invasions (Haddad et 
al, 2005). Increased IL-6 levels are demonstrated alongside chronic intramuscular 
inflammation in mdx mice (Kostek et al, 2012) and it is proposed that this represents a 
biomarker of catabolic muscle metabolism. 
In vitro study of biochemical markers of muscle regeneration and degeneration in a DMD 
population reported significant increases in biomarkers of muscle degeneration (such as Fas; 
FasL – associated with Tumour Necrotising Factor) and a simultaneous increase in some 
biomarkers of muscle regeneration in the presence of a decrease in others, as compared to 
normal blood biomarker levels in age- & sex-matched, unaffected controls. This indicates an 
environment of accelerated muscle degeneration and insufficient muscle regeneration in DMD 
individuals leading to overall tissue damage and disorganisation (Abdel-Salam et al, 2009). 
Furthermore, frequent physical activity in geriatric populations has demonstrated a regulatory 
effect on levels of IL-6 (Jankord & Jemiolo, 2004), indicating an anti-inflammatory effect of 
physical activity on muscle tissue. A combination of chronic, low-level inflammation evidenced 
by elevation of intramuscular IL-6, deranged balance of muscle degeneration and 
regeneration markers and a lack of the protective effects of regular physical activity in 
individuals with MD provide a further mechanism to suggest that muscle atrophy should exist 
in adults with the condition. However, as previously mentioned, there is no published data 
from adult males with any form of muscular dystrophy compared to age-matched controls.   
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Skeletal health in muscular dystrophy 
Inexorably linked to this descriptive evidence of muscular alterations in MD is its association 
with Bone Mineral Density (BMD) and the regulatory effect of significant and substantial 
tensile and compression forces on BMD maintenance. As described by Frost's 'mechanostat' 
theory and subsequent Utah Paradigm a minimum threshold of microstrain force must be 
achieved before bone tissue enters a homeostatic or anabolic metabolism (Frost, 2003). 
Forces below a minimum threshold do not promote regulatory osteocyte or constructive 
osteoblast activity. Frost further described how the intensity of the force experienced by the 
bone tissue correlated to the regulatory effect on BMD i.e. the more significant the force 
(within limitations of a stress-strain relationship) the more prominent the metabolic response 
in preserving BMD. Rittweger, in a festschrift review in 2008, identifies the critical link 
between BMD preservation and tensile strain through muscle force generation (particularly 
during adolescence where bone mass is most significantly accrued). Despite the supposed 
clarity of this linear model, Rittweger identified a further component of BMD regulation; 
Eventual adult joint size - governed by forces experienced in bone during childhood – directly 
limits peak force transmission in bone during adulthood. This therefore provides a caveat 
explaining the unpredictability in linear models describing the effect of interventions (such as 
bone loading exercise) and their impact in generating improvements in BMD as adult joint 
size appears to impose limitations on BMD gains through appropriate bone loading exercise. 
 
Previous studies have demonstrated how immobility forms part of a complex of factors in 
BMD regulation (Zerwekh et al, 1998) and prolonged immobility secondary to skeletal muscle 
weakness will have a negative impact upon BMD. Additionally, recent medical advances in 
condition management have led to the routine prescription of long-term corticosteroid 
therapies in DMD adolescents. Individuals with DMD using frequent corticosteroidal anti-
inflammatory therapy experience fewer skeletal deformities and prolonged ambulation relative 
to those untreated, however they also experience a significant increase in incidence of 
vertebral fractures; with an estimated incidence in one study of between 17-32% of 
corticosteroid treated individuals compared to no fractures in untreated individuals over a 
three year period (King et al, 2007). Long bone fracture rates have been reported to be similar 
between corticosteroid and non-corticosteroid users in DMD children (mean age 13.1 years). 
However in some of the literature (Houde et al, 2008) elevated levels of lower limb fractures in 
MD populations (9% DMD – 0% controls) has also been described (Vestergaard et al, 2001). 
It is worth noting that the populations in these studies differed in mean age significantly (13.1 
years – Houde et al, 23.9 years – Vestergaard et al). Older DMD individuals are likely to 
experience more marked levels of physical disability; more significant impairments to 
ambulation and mobility and therefore may have more significant impairments of bone health 
compared to younger individuals who may remain ambulant or have lost ambulation more 
recently.  
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Fracture incidence was recorded by Larson & Henderson (2000) as part of demographic data 
collected during their study of BMD in DMD individuals. The authors identified that 44% (18 
individuals) of the 41 adolescent participants scanned sustained a fracture, with 66% of these 
occurring in the lower limbs. BMD as assessed by Z-score (a relative score of BMD compared 
to the reference mean of an age-matched demographic) was reduced in DMD individuals 
most significantly in the proximal femur (mean z-score -1.6) - (despite ambulation) and 
additionally in the lumbar spine but only following loss of ambulation (mean z-score -1.7).  
 
Confirming anticipation of compromised bone health in DMD individuals, Bianchi et al (2003) 
investigated cortical steroid impact on BMD in their study of 32 DMD boys (22 – steroid, aged 
4-17years, mean age 9.9; 10 – non-steroid, aged 4-15 years, mean age 10) by Dual-Energy 
X-ray Absorptiometry (DXA). They identified reduced BMD z-scores at lumbar spine vertebral 
bodies in both groups; with further significant reductions demonstrated in the corticosteroid 
group compared to the non-corticosteroid group (mean t-score; steroid -4.0, non-steroid -3.5). 
Furthermore, Bianchi identified through blood analysis, marked reduction in hydroxyvitamin D 
levels and hypocalciuria – markers of calcium metabolism – indicating deranged bone 
turnover at the site investigated. Further specific assessment of 10 ambulatory individuals 
with DMD (mean age 8 years) was undertaken by Aparicio et al (2002) whereby substantial 
reductions in femoral and vertebral Z-scores (-4.32 and -3.47 respectively) were identified. 
 
Whilst BMD is likely to be significantly reduced in DMD individuals due to factors such as 
enforced immobilisation and the degree of bone loading, medical factors such as 
corticosteroid use can further impact upon bone health. Soderpalm et al (2008), in addition to 
confirming Bianchi et al‟s (2003) biochemical data of bone biomarker derangement, 
completed DXA scans of whole-body (with/without head excluded), spine, hip and heel – 
identifying reduced Z-scores at all sites in 24 DMD boys (2-19 years), the majority of whom 
were undergoing prednisolone therapy. Reductions in all sites were confirmed with age after a 
4-year follow-up.  
 
Corticosteroid therapy has been demonstrated to contribute to significant reductions in BMD 
in the earlier work of Hawker et al (2005). This observation of impaired bone health was not 
affected by dependency on dose in subsequent studies by Crabtree et al (2010) and Houston 
et al (2014) who used BMD assessed by DXA as a primary outcome measure for dosage 
trials of corticosteroid therapy – all studies identified reductions in BMD at specific sites in 
Table 2.0. It is worth noting that Crabtree et al in their study adjusted recorded BMD Z-scores 
for lean body mass and height measurements. This post-hoc analysis was not performed by 
other authors and in doing so recorded BMD Z-scores did not achieve statistical significance 
compared to control data. 
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The only study currently to investigate BMD in adults with MD was undertaken by Philippe et 
al (2011). A total of 15 DMD individuals (mean age 27); 18 LGMD individuals (mean age 40); 
and 12 FSHD individuals (mean age 45) were scanned at the femoral neck and spine with 
results describing reduced T-scores (a relative score of BMD as compared to the mean score 
of a healthy, thirty-year-old reference adult) in all groups as assessed by DXA (Figure 1.2). 
Particular reductions were observed in those individuals who were non-ambulant compared to 
those who remained independently mobile in both anatomical sites. DMD individuals 
presented with the lowest relative BMD – the severity of their condition perhaps leading to 
earlier dependence upon wheelchair mobility aids and reducing overall lifetime loading of 
lower limb bones, whereas there was some preservation of BMD in the MD in which 
ambulation was possible (Table 2.0). Philippe et al represents the broadest investigation of 
BMD in individuals affected by a variety of MD. However their use of T-scores as an outcome 
measure is less age-appropriate than a Z-score and their omission of a distal lower limb scan 
site prevents completion of the data (it is estimated that up to 35% of DMD individuals 
experience a tibial fracture and 44% experience foot/ankle fractures (Vestergaard et al 2001).  
 
 
Fig 1.2 Relative T-scores of adult individuals affected by three types of dystrophy at femoral neck and lumbar spine 
highlighting particular reductions in individuals affected by DMD (Philippe et al 2011) 
 
While literature investigating BMD in MD has been conducted more recently and by a larger 
number of studies than those describing muscle composition there is a near unanimous focus 
on DMD participants (particularly adolescent populations) and no study has yet investigated 
the correlation between muscle mass and BMD in any form of MD. 
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Table 2.0 Summary of Bone Density measures from individuals with MD.  
Author Dystrophy Population Methods Results 
Bianchi et al 
2003 
DMD  N = 32 
Mean age = 10 years 
DXA Lumbar spine vertebrae 
 
Biomarker blood test 
Steroid z-score mean = - 4.0 
Non-steroid z-score mean = - 3.5 
Reduced markers of bone anabolism 
Houston et 
al, 2014 
DMD 
retrospective 
study 
N = 39 
Mean age at study start = 3.5 
Mean age at study end = 18.6 
DXA Lumbar Spine 
 
DXA femur 
Steroid z-score mean = - 1.12 
Non-steroid z-score mean = - 2.04 
Steroid z-score mean = - 3.30 
Non-steroid z-score mean = - 3.30 
Hawker et 
al, 2005 
DMD  N = 42 
Mean age = 11 years 
DXA Lumbar spine vertebrae Z-score mean =        -1.94 
Crabtree et 
al, 2010 
DMD  N = 25 
5-12 years 
DXA subcranial bone and 
Lumbar spine 
Z-score mean Lumbar spine = - 1.4 
Subcranial = - 3.0 
Soderpalm 
et al, 2008 
DMD  N = 24 
Mean age = 12 years 
DXA – whole body (+/- 
cranium inclusion), lumbar 
spine, hip & heel 
 
Biomarker blood test 
Mean Z-score =  
- 2.5 
 
 
Reduced markers of bone anabolism 
Larson & 
Henderson, 
2000 
DMD  N = 41 
Ambulant and non-ambulant 
DXA Lumbar spine vertebrae  
 
DXA femur 
Z-score amb = - 0.8 
Non-amb = - 1.7 
Z-score amb = - 1.6 
Non-amb = - 3.9 
Aparicio et 
al, 2002 
DMD  N = 10 
Mean age = 8 years 
DXA Lumbar spine vertebrae 
DXA femur 
Z-score mean =   - 4.32 
Z-score mean =   -  3.47                                                 
Philippe et 
al, 2011 
DMD, LGMD, 
FSHD  
DMD = 15 
LGMD = 18 
FSHD = 12 
Adults 
DXA Lumbar spine vertebrae 
(T-score mean) 
Total amb = - 0.25 
Total non-amb = - 3.16 
DXA femur (T-score mean) 
Total amb = - 1.17 
Total non-amb = - 2.81 
DMD t-score mean = - 4.0 
LGMD t-score = -  0.8 
FSHD t-score = - 0.7 
DMD t-score mean = - 2.5 
LGMD t-score = - 1.7 
FSHD z-score = - 1.1  
 
Physical activity is known to contribute significantly in all-cause mortality and general health 
(Iannuzzi-Sucich et al 2002). More specifically, intense physical activity provides stimuli for 
muscle accumulation and maintenance. The effects of bone loading through physical activity 
have also been demonstrated to have a profound effect on bone geometry and density thus 
having a positive effect on its quality and quantity (Kelley et al, 2013). Combination effects of 
ongoing corticosteroid therapy and reduced physical activity have also been demonstrated to 
reduce bone tensile strength and geometric architecture of bone in mdx mice (Novotny et al, 
2012). Muscle weakness and detraining contribute to reductions in physical activity in all 
demographics, with previous studies identifying a correlation between lower limb strength and 
functional activities (e.g. stair climb) in elderly populations (Bean et al, 2007). It is reasonable 
to expect this to be more pronounced in individuals affected by muscle wasting conditions - 
particularly in severely affected individuals reliant upon powered wheelchairs for mobility. 
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As evidenced, a complex number of factors including physical activity and bone loading 
influence BMD and muscle size, particularly in children (Table 1 and 2). Characteristic of MD 
is a high intra- and inter-condition variability in clinical presentation, muscle weakness and 
disease progression with MD representing a spectrum of functional deficit - with some 
individuals requiring permanent support of powered mobility aids from early adolescence, 
some individuals maintaining high levels of regular physical activity (vocational, leisure, etc.) 
into late adulthood. Individuals who are less severely affected by functional impairment 
related to muscle tissue damage are likely to maintain higher levels of physical activity and 
maintain independent ambulation for a higher proportion of lifespan. Given the importance of 
stress and loading in physiological feedback systems of muscle and bone regulation, early 
loss of ambulation is likely to accelerate muscle atrophy and loss of BMD (Fig 1.3), whereas 
prolonged physical activity is likely to delay deleterious effects on muscle and bone. It is 
therefore reasonable to assume; individuals with more severe levels of muscle impairment 
are more likely to demonstrate decline in physiological markers of muscle size and BMD 
earlier than those with less severe disease presentations.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 1.3 Flowchart describing process effects on BMD and muscle as a result of muscle condition presence 
 
The focus of previous published studies in muscle and bone has largely been small, 
adolescent DMD populations; this represents a minor (though severely affected) proportion of 
the population of individuals affected by MD. Previous studies have also largely focused on 
either muscle structure or bone density, with no study thus far describing the two variables in 
one group of participants. 
 
Aim 
The aim of this study is to describe a data set of muscle cross-sectional area (tibialis anterior 
(TA)) and bone mineral density in upper (distal radius (DR)) and lower (midshaft tibia (MST)) 
limbs in adult males affected by a variety of dystrophies.  
Genetic defect leading to muscle 
inflammation 
Muscle damage resulting in 
weakness and reduced endurance  
Loss of/reduced ambulation  
Reduced physical activity  Reduced weight-bearing force on bone Reduced voluntary muscle use 
Reduced BMD and lean muscle 
content 
18 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CHAPTER 2- METHODS 
19 
 
Participants 
A total of 39 males with four distinct variants of MD - 10 individuals with DMD (Aged 25.4 ± 
5.4 years), 10 individuals with BeMD (Aged 38.2 ± 11.7 years), 9 individuals with LGMD 
(Aged 37.1 ± 13.8 years), 10 individuals with FSHD (Aged 46.3 ± 10.3 years) - were recruited 
prospectively from a cohort of adults (>18 years old) regularly attending the Neuromuscular 
Centre (NMC), Cheshire, UK – a national centre of excellence for adults with MD. A group of 
10 adult males without any form of neuromuscular impairment were recruited as a control 
group (Aged 23.0 ± 4.9 years) (CTRL) (Table 3.0). 
All individuals with MD had previously received a laboratory confirmed diagnosis of MD 
through genetic testing at specialist NHS clinics. 
All MD individuals recruited for the project were medically fit enough to attend a physiotherapy 
appointment (MD individuals attended the NMC on a regular (1-, 2-, 4-weekly) basis as part of 
a program of physiotherapy intervention aimed at maintaining function and independence). All 
CTRL participants were untrained, recreationally active and self-reported as undertaking no 
more than 1 hour of intense physical activity per week (Activities approximately >6 Metabolic 
Equivalents such as competitive sport, aerobics etc). CTRL participants were staff and 
students at Manchester Metropolitan University; staff members of the NMC physiotherapy or 
administrative team; carers or personal assistants to individuals attending the NMC. 
 
Ethics 
Ethical approval was obtained through the Department of Exercise and Sport Science, 
Manchester Metropolitan University and all participants signed informed consent prior to 
taking part in the study. All procedures complied with the latest revision of the Declaration of 
Helsinki (WMA 2013). 
 
Condition Population (n) Ambulant (n) Age (years) Mass (kg) Stature (cm) 
CTRL 10 10 23 ± 5.0 (Range 19-37) 84.5 ± 10.5 182.4 ± 9.5 
DMD 10 0 25 ± 5.8 (Range 20-38) 67.0 ± 17.5 164.7 ± 12.9 
BeMD 10 8 38 ± 11.9 (Range 22-59) 87.3 ± 15.7 179.6 ± 8.0 
FSHD 10 9 46 ± 10.6 (Range 33-58) 91.5 ± 20.6 183.9 ± 7.9 
LGMD 9 7 37 ± 13.8 (Range 18-63) 90.1 ± 20.5 177.3 ± 10.2 
 
Table 3.0: Participant demographic data, population size and ambulatory status for adult males unaffected by MD 
(CTRL); adult males affected by Duchenne MD (DMD); adult males affected by Becker MD (BeMD); adult males 
affected by facioscapulohumeral MD (FSHD); and adult males affected by Limb Girdle MD (LGMD). Data are 
presented as Mean ± Standard Deviation. 
 
Protocol 
Participants were tested on a single occasion with bone and muscle measurements 
performed in a random order during the same session in an outpatient clinic environment.  All 
muscle, bone, and grip measurements were taken from the participant‟s dominant upper and 
lower limb as identified by subjective verbal questioning.  
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Ultrasound setting such as depth, brightness, gain etc were optimised to permit ease of 
identification of connective tissue septa during site identification and scanning. Surface 
markings were made on the skin with indelible pen over the region of interest.  
 
Anthropometric measures were collected as follows:  
Stature: 34 Ambulatory individuals able to stand erect were measured using a 
stadiometer (Harpenden stadiometer, Holtain Crymych, UK). 15 individuals dependent upon a 
wheelchair or able to stand but unable to achieve an erect posture were measured via arm 
span measurements with use of a tape measure (individuals with marked contractures were 
measured point-to-point; middle finger, elbow crease, corocoid process, midline sternum). 
Arm span measurements have been demonstrated to be a valid method of measuring height 
in adults (Brown et al, 2000). 
 
Mass: All individuals were weighed using a digital seated scale system (6875, 
Detecto, Webb City, MO, USA) sensitive to the nearest 100 grams. In MD participants, the 
weight of slings, splints, shoes etc was subtracted from gross weight following separate 
measurement. CTRL participants were weighed standing, using a digital scale (Seca model 
873, Seca, Germany), clothed, but unshod. The degree of agreement between the two scales 
was assessed by use of a 5kg metal weight. The degree of agreement was within 2% of 
weight measured.  
 
Steroid Therapy 
As previously demonstrated, long-term steroid therapy is known to adversely affect BMD. 
None of the individuals of the DMD group were currently on long-term steroid therapy, with 2 
individuals having discontinued long-term steroid therapy at least 2 years prior to enrolment 
on the study. No individuals of any other group were using or had previously been prescribed 
long-term steroid therapy for a period of more than 1 year.  
 
Muscle ASCA 
ASCA of the Tibialis Anterior (TA) muscle was assessed using a (MyLab25, Esaote 
Biomedica, Genoa, Italy) brightness mode (B-mode), real-time ultrasound scanning device at 
7.5 MHz frequency (linear array) with aqueous gel as contact medium (Cardiacare Ltd 
Ultrasound Gel, Cardiacare Limited, Brentwood, UK). During assessment of the lower limb 
individuals were in a relaxed, seated position with the knee fully extended and the calcaneus 
supported to ensure limb stability due to the fibrous nature of tissue associated with MD – 
particularly evident in dystrophinopathies – full knee extension to a straight leg was often 
unachievable due to joint and soft tissue contractures. Muscle deformation as a function of 
stretch in this position should not cause differences in muscle Anatomical Cross-Sectional 
Area (ASCA) between those able to achieve full knee extension and those with restricted joint 
range due to the positioning of the TA. Confounding muscle deformation as a result of stretch 
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during a ASCA assessment may occur during observation of a passively insufficient, two-joint 
muscle such as the Gastrocnemius Medius in knee extension; however this position does not 
affect the TA due to its sole role in ankle dorsiflexion. The TA was chosen as it was 
accessible in the non-ambulatory MD participants and has been extensively used in studies 
observing human muscle ASCA, volume and body composition (Abe et al, 1994). 
 
TA insertion to tibial periosteum was established proximally and distally by sonographic 
assessment of its osseotendinous junction and a tape measurement from surface markers 
allowed the site to be calculated based upon TA length.  The transducer head was applied in 
a transverse plane to the limb and a single, real-time image was sufficient to capture the TA 
muscle boundary. Care was taken to maintain a consistent application of pressure on the 
ultrasound transducer to prevent deformation of soft tissue through mechanical means. Real-
time ultrasound recording was performed at 25 fps (Adobe Premier pro Version 6). Images 
taken through transverse scanning were digitally reconstructed (ImageJ 1.45, National 
Institutes of Health, USA) and ASCA established through computerised measurement. ASCA 
measurements were taken at 20% muscle length distal to the proximal origin where the 
muscle thickness has been demonstrated to be maximal (Martinson & Stokes, 1991). 
 
B-mode ultrasound has been demonstrated to be valid in obtaining accurate data on muscle 
ASCA. It has previously compared favourably in terms of accuracy in delineating muscle/bone 
and muscle/fat divisions with gold-standard assessments such as MRI (Miyatani et al, 2004). 
Deviations from data obtained by MRI have been estimated to range from -0.15% to 5.17% 
(Esformes et al, 2002) indicating a valid and reproducible outcome measure, with a reported 
interclass correlation of 0.998 (reliability) and 0.999 (validity) compared with MRI (Reeves et 
al, 2004). Furthermore, ultrasound machines do not carry the burden of cost and 
impracticality compared to MRI and are realistic and viable alternatives in a field setting such 
as the NMC physiotherapy department.  
 
Grip Strength 
Muscle strength has previously been demonstrated to indicate bone health (Snow-Harter et 
al, 1994). Specifically, grip strength has been demonstrated to be a valid, independent 
indicator of upper limb bone health and density in healthy populations – higher grip strength 
correlates positively with higher BMD and overall bone health. This correlation has been 
estimated to account for up to 16.8% of the variation of BMD within a healthy population 
(Kritz-Silverstein & Barrett-Conner, 1994). At present, grip strength is considered as part of a 
complex of factors predicting BMD and is not clinically used as a predictor of BMD; therefore 
specific data concerning the predictive accuracy of grip strength for BMD is not available. 
Individuals who were capable of producing a measurable contraction of the hand completed a 
grip strength assessment by means of an analogue dynamometer. Dynamometer 
measurements were made subsequent to muscle ultrasound scans to prevent significant fluid 
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shifts influencing muscle volume assessment (Berg et al, 1993). Individuals were required to 
produce three, 5-second duration, 1-minute interval, maximal-effort grip contractions with their 
self-reported dominant hand whilst in a seated position. Maximal recorded reading of grip 
strength was reported.  
 
11 individuals (22% of the total cohort) with advanced disease progression or severity (10 
DMD; 1 BeMD) could not generate significant muscle force to effect a measurement on the 
equipment. 
 
Dynamometers have been used to measure strength for a number of decades and are an 
accepted means of obtaining a value for muscle strength more accurately than therapist-
performed manual muscle testing. Hand-held dynamometers have been demonstrated to 
have a re-test accuracy of up to 99% (Janssen and Le-Ngoc, 2009).  
 
Bone Mineral Density 
BMD assessment of the distal radius and mid-shaft tibia were recorded using a (Sunlight 
Omnisense 8000 portable, BeamMed Ltd, Petah Tikva, Israel) Speed of Sound (SoS) bone 
density ultrasound scanner, with aqueous gel as contact medium. Prior to any data collection 
the machine was calibrated using a Lucite reference block to correct for ambient temperature 
fluctuations and ensure reliability. During assessment of the limb individuals were seated in a 
relaxed position with their upper limb resting upon the armrest of the chair/wheelchair, 
separated from the surface by a foam spacer, with elbow flexed to 90°, fingers fully extended 
and the wrist in a neutral position. During lower limb observation the individual was seated in 
a relaxed position with hip and knee aligned, full knee extension (with respect to limitations 
imposed by soft tissue and joint contractures) and their calcaneus supported to ensure limb 
stability during testing. Data collection of BMD values in the upper and lower limb was based 
on sites recommended by the manufacturer for use with their equipment; distal radius and 
midshaft tibia.  
 
DR measurements were obtained by measuring the distal arm length from the olecranon 
process of the elbow to the tip of the third distal phalanx. Measurement was performed on the 
dorsal aspect of the limb to avoid complications with individuals with contractures at elbow 
and/or wrist. All individuals were assessed on their self-reported dominant hand to exclude 
confounding influences of asymmetry. The investigation site was determined at 25% of total 
limb length proximal to the tip of the third phalanx at the lateral aspect of the radius relative to 
standard anatomical position following manufacturer‟s instructions. The transducer was 
placed in a coronal plane and aligned caudad-cephalad relative to the limb in anatomical 
position. A total of three data collections were performed by a slow, repeated oscillation of the 
transducer in an arc over the surface of the radius to ensure ultrasonic transduction through 
the entire bone. 
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This observation site has a physiological, in addition to, clinical significance. At the point of 
assessment the radius is composed of primarily cancellous bone with a trabecular 
arrangement indicating a substantial role in stress transmission through the upper limb (Hsu 
et al, 1993). Proximal to this site the bone transitions to a cortical structure with intermedullary 
marrow. Distal to this site and the bone transitions to an epiphyseal structure with greater 
concentrations of sclerosed bone (once adulthood has been reached). Transmission of SoS 
ultrasound at these sites would be compromised by changes in the refractive value of the 
bone tissue and a true indication of BMD would be more difficult to accurately obtain. 
Furthermore, the DR is a common area of fractures related to falls. The „Colles‟ fracture of the 
distal radius is one of the most common upper limb fractures with an estimated incidence of 
0.29% in male populations of every age (Mallmin and Lljunghall, 1992). Recently, DR sites 
have been used in addition to the established sites of lumbar spine and femoral neck in BMD 
scanning as part of detection of osteoporosis. Forearm fractures are reliable determinants of 
future fracture risk in other sites, with a cumulative incidence of whole-body fractures of 55% 
10 years following a forearm fracture and 80% 20 years post-fracture (Cuddihy et al, 1999).  
 
MST measurements were based upon a tape measurement of lower leg length from tibial 
plateau (identified through palpation of knee joint line) to base of calcaneus. All individuals 
were assessed on their dominant lower limb as identified by subjective verbal questioning. 
Individuals with MD often report asymmetrical symptoms in lower limbs, particularly those 
associated with muscle weakness; however there is often variable weakness between 
individual muscle groups on the same leg (e.g. weak glutei may lead to an ipsilateral calf 
musculature hypertrophy as a compensatory mechanism). As such it would be difficult to 
accurately assess a dominance of lower limbs through muscle strength testing alone, 
particularly as these tests are often not sensitive enough to detect subtle differences in 
muscle strength. The investigation site was determined at 50% of the total limb length 
proximal to the calcaneus on the anterior aspect of the tibia (tibial spine). The transducer was 
placed in a sagittal plane and aligned caudad-cephalad relative to the limb. Three data 
collections were performed with a slow, repeated oscillation of the transducer in an arc over 
the surface of the tibia to ensure ultrasonic transduction through the entire bone. 
 
The site of the MST is an important area of trabecular concentration (similar in composition to 
the DR). Given associated reductions in BMD in individuals affected by MD, a pattern of 
reduction will be more prevalent distally in individuals who are non-weightbearing. In a cohort 
of 378 ambulant and non-ambulant DMD children (Aged 1-25years, mean age 12 years), 40% 
of 102 fractures sustained during the period of investigation occurred in the lower limb – with 
15% of all fractures involving the tibia, implicating the distal lower limb as an important clinical 
site for BMD investigation (McDonald et al, 2002) 
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The ultrasound data outputs are expressed as - T-scores (a relative score of BMD as 
compared to the mean score of a healthy, thirty-year-old reference adult) and a Z-score (a 
relative score of BMD compared to the reference mean of an age- & gender-matched 
demographic) – relative indications of BMD. T-scores are routinely used as a screening and 
diagnostic tool in osteoporosis (OP); with a T-score of <-2.5 SD considered as manifest 
osteoporosis (Johnell et al, 2005). While T-scores remain prevalent in the diagnosis of OP, 
the Z-score represents deviation from a norm of demographically-matched individuals and 
may be of more significance in individuals undergoing long-term intervention (such as 
steroids) or those with long-term conditions. Z-scores as a statistical device are frequently 
seen in large-scale studies of chronic conditions such as Chronic Liver Disease (Sokol and 
Stall, 1990) and childhood obesity (Cole et al, 2000). 
Assessment of BMD is clinically performed more commonly by either Peripheral Quantitative 
Computed Tomography (pQCT) or Dual-energy X-Ray Assessment (DXA) being the gold 
standard for diagnostic accuracy. However, both devices use ionising radiation and within the 
cohort of the DMD patients it is difficult to maintain posture during the duration of the scan, 
alongside issues of gantry size within the pQCT. 
 
SoS quantitative ultrasound, while lacking credentials for use in definitive clinical diagnoses of 
adverse bone health, has been shown to be an effective screening tool in the identification of 
OP, particularly in conjunction with known risk factors (Minnock et al, 2008). Ultrasound as a 
means of assessing BMD is as sensitive as DXA to OP risk factors (Frost et al, 2001) and 
compares favourably with pQCT measures of BMD and bone composition (Lee et al, 1997). It 
is also of a non-invasive ionising radiation thus being an ideal portable screening tool for bone 
tissue analysis. Furthermore, due to soft tissue contracture and pseudohypertrophy of lower 
limb musculature, reliable pQCT measurements from certain clinical populations (e.g. 
dystrophinopathies) are impossible due to complications regarding limb position and size as 
previously highlighted.  
 
Physical Activity 
Physical activity is a key determinant of life-long BMD. Due to reductions in ambulation and 
functional ability, individuals with mobility-limiting disabilities often present with significant 
reductions in physical activity. As such, standard subjective measurements of physical activity 
are unlikely to be sensitive enough to capture individuals with MD – particularly those with the 
most significant physical impairment.  
 
Washburn et al (2002) developed a disability specific physical activity questionnaire (PASIPD 
– Physical Activity Score for Individuals with Physical Disabilities) to account for reduction in 
physical activity associated with various physical disabilities. This encompasses a lower 
activity threshold and has subsequently been validated as a reliable outcome measure for 
physical activity in disabled persons (van der Ploeg et al, 2007).  
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The Bone Specific Activity Questionnaire (BPAQ) was developed by Weeks & Beck (2008) to 
account for variations in mechanical bone loading activity and their effect on BMD. It has 
subsequently been used in multiple studies describing interventions in bone loading (e.g. 
Beck & Norling, 2010) and as part of data abstraction in meta-analyses of bone changes post-
exercise intervention (e.g. Kelley et al, 2012). 
 
MD individuals were required to complete both physical activity questionnaires with support of 
the researcher. 
 
Statistics 
IBM SPSS Statistics 21 was used to analyse the data. Parametricity was established with use 
of a Shapiro-Wilk test of normality and a Kolgomorov-Smirnov test of equal variance – TibAnt 
ASCA and PASIPD score data satisfied the criteria of parametricity. Age, BPAQ score, Grip 
strength, Mass, Span, T-score Radius, T-score Tibia, Z-score Radius and Z-score Tibia all 
failed to satisfy criteria of normal distribution.  
All data (including that generated by the PASIPD and BPAQ) was ordinal in nature. Intergroup 
means of demographic, muscle ASCA, bone, physical activity, and grip data were compared 
with use of a one-way ANOVA with post-hoc pairwise comparisons, using LSD adjustments. 
GreenHouse Geisser corrections were applied to the above data failing to satisfy normal 
distribution. Intergroup percentage deviations and figures were produced using functions in 
Microsoft Excel 2013. Data are presented as Mean± Standard Deviation (STDEV) unless 
otherwise indicated. Statistical significance was set with =0.05. 
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DMD had a lower age compared with all groups except CTRL (BeMD -50.5%; FSHD -82.4%; 
LGMD -46.3%) (P<0.05, Table 4.0).  
All groups (except DMD participants) demonstrated higher age compared with CTRL (BeMD 
+65.4%; FSHD +100.0%; LGMD +60.7%). There were no differences demonstrated between 
any other groups in age.  
 
DMD had lower mass compared to all groups (BeMD -23.3%; FSHD -26.8%; LGMD -25.6%; 
CTRL -20.7%) (P<0.05 Table 4.0). There was no difference between FSHD, LGMD, BeMD or 
CTRL in mass. 
 
DMD demonstrated lower stature compared with all other groups (BeMD -8.27%; FSHD -
10.4%; LGMD -7.11%; CTRL -9.67%) (P<0.05 Table 4.0). There was no difference identified 
in stature between any other groups. 
 
DMD demonstrated lower radial T-scores compared with all groups except BeMD and FSHD, 
and lower Z-scores compared with all groups except BeMD and FSHD. All groups 
demonstrated reduced radial T- and Z-scores compared with CTRL except LGMD. All groups 
demonstrated reduced radial T- and Z-scores compared with LGMD except CTRL. (P<0.05 
Table 4.0, Figure 1.4). There were no further differences between groups. 
 
DMD demonstrated lower tibial T- and Z-scores compared with all groups. There were no 
differences in tibial T- and Z-scores between any other groups. (P<0.05 Table 1.1, Figure 
1.5). 
 
All groups demonstrated lower TA ASCA compared with CTRL (BeMD -39.7%; DMD -59.7%; 
FSHD -58.9%; LGMD -62.4%). BeMD demonstrated lower TA ASCA compared with CTRL 
and higher TA ASCA compared with all other groups. There were no further differences 
between other groups in TA ASCA (P<0.05 Table 1.1, Figure 1.6).  
 
DMD demonstrated lower grip strength compared with all groups. All groups demonstrated 
lower grip strength compared to CTRL (BeMD -51.2%; FSHD -46.3%; LGMD -49.9%). There 
was no difference in grip strength between LGMD, FSHD and BeMD. (P<0.05 Table 4.0, 
Figure 1.7)  
 
DMD demonstrated significantly lower mean BPAQ (P<0.05 Table 4.0, Figure 1.8) and 
PASIPD (P<0.05 Table 4.0, Figure 1.9) score compared with BeMD, FSHD and LGMD. There 
were no differences in physical activity scores between with BeMD, FSHD, LGMD. 
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 CTRL BeMD DMD FSHD LGMD 
Age (years) 23 ± 5.0 38 ± 11.9*† 25 ± 5.7 46 ± 10.6*† 37 ± 13.9*† 
Stature (cm) 182.4 ± 9.5 179.6 ± 8.0† 164.7 ± 12.9*  183.9 ± 7.9† 177.3 ± 10.2† 
Mass (kg) 84.5 ± 10.5 87.3 ± 15.7†  67.0 ± 17.5* 91.5 ± 20.6† 90.1 ± 20.5† 
T-Score 
Radius 
0.7 ± 0.7 -0.68 ± 1.0* -1.18 ± 1.2* -0.4 ± 0.8* 0.04 ± 1.0† 
Z-score 
Radius 
0.96 ± 0.7 -0.53 ± 1.1* -0.88 ± 1.2* -0.2 ± 0.8* 0.22 ± 0.9† 
T-score Tibia -0.09 ± 0.5 -0.4 ± 0.7† -1.32 ± 1.0* 0.2 ± 1.0† 0.2 ± 0.8† 
Z-score Tibia -0.06 ± 0.6 -0.35 ± 0.8† -1.29 ± 1.0* 0.3 ± 1.0† 0.29 ± 0.8† 
Tib Ant ASCA 
(cm
2
) 
9.57 ± 2.6‡ 5.77 ± 1.6* 3.86 ± 1.2*‡ 3.9 ± 1.5*‡ 3.6 ± 0.7*‡ 
Grip (kg) 44 ± 7.20 21.5 ± 19.2*† 0.0 ± 0.0*$ 23.6 ± 15.5*† 22.1 ± 12.1*† 
PASIPD 
score 
N/A 18.4 ± 21.1† 1.10 ± 0.6 12.2 ± 11.8 11.7 ± 7.8 
BPAQ score N/A 19.4 ± 15.2† 2.17 ± 2.3  22.2 ± 14.1† 24.9 ± 13.7† 
 
Table 4.0: Participant demographics, bone health scores, TA ASCA, and grip strength for Adult males without 
muscular dystrophy (CTRL); adult males with Becker muscle dystrophy (BeMD); adult males with Duchenne 
Muscular Dystrophy (DMD); adult males with Facioscapulohumeral Muscular Dystrophy (FSHD); and adult males 
with Limb Girdle Muscular Dystrophy (LGMD). Data are presented as Mean ± SD. * Denotes significant difference 
from CTRL, † denotes significant difference from DMD, ‡ denotes significant difference from Becker‟s MD, $ denotes 
inability for participants in this group to perform the required data collection test (P<0.05) (PASIPD = Physical Activity 
Scale for Persons with Physical Disabilities; BPAQ = Bone-specific Physical Activity Questionnaire) 
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Fig 1.4 Radial Z-scores of adult males affected by Becker Muscular Dystrophy (BeMD), adult males affected by 
Duchenne Muscular Dystrophy (DMD), adult males affected by Facioscapulohumeral Muscular Dystrophy (FSHD),  
adult males affected by Limb Girdle Muscular Dystrophy (LGMD) and unaffected adult male controls (CTRL). Data 
are presented as Mean ± standard deviation error bars. * denotes significant difference from CTRL. 
 
 
Fig 1.5 Tibial Z-scores of adult males affected by Becker Muscular Dystrophy (BeMD), adult males affected by 
Duchenne Muscular Dystrophy (DMD), adult males affected by Facioscapulohumeral Muscular Dystrophy (FSHD),  
adult males affected by Limb Girdle Muscular Dystrophy (LGMD) and unaffected adult male controls (CTRL). Data 
are represented as Mean ± standard deviation error bars. * denotes significant difference from CTRL. 
 
 
* 
* 
* 
* 
* 
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Fig 1.6 TA ASCA of adult males affected by Becker Muscular Dystrophy (BeMD), adult males affected by Duchenne 
Muscular Dystrophy (DMD), adult males affected by Facioscapulohumeral Muscular Dystrophy (FSHD),  adult males 
affected by Limb Girdle Muscular Dystrophy (LGMD) and unaffected adult male controls (CTRL) presented in cm
2
. 
Data are presented as Mean ± standard deviation error bars. * denotes significant difference from CTRL. 
 
 
 
Fig 1.7 Grip strength of adult males affected by Becker Muscular Dystrophy (BeMD), adult males affected by 
Duchenne Muscular Dystrophy (DMD), adult males affected by Facioscapulohumeral Muscular Dystrophy (FSHD),  
adult males affected by Limb Girdle Muscular Dystrophy (LGMD) and unaffected adult male controls (CTRL) 
presented in kg. Data are presented as Mean ± standard deviation error bars. * denotes significant difference from 
CTRL. 
 
 
* * * 
* * 
* 
31 
 
 
Fig 1.8 BPAQ scores of adult males affected by Becker Muscular Dystrophy (BeMD), adult males affected by 
Duchenne Muscular Dystrophy (DMD), adult males affected by Facioscapulohumeral Muscular Dystrophy (FSHD), 
and adult males affected by Limb Girdle Muscular Dystrophy (LGMD). Data are presented as Mean ± standard 
deviation error bars. † denotes significant difference from DMD. 
 
 
Fig 1.9 PASIPD scores of adult males affected by Becker Muscular Dystrophy (BeMD), adult males affected by 
Duchenne Muscular Dystrophy (DMD), adult males affected by Facioscapulohumeral Muscular Dystrophy (FSHD), 
and adult males affected by Limb Girdle Muscular Dystrophy (LGMD). Data are presented as Mean ± standard 
deviation error bars. † denotes significant difference from DMD. 
 
 
 
 
 
 
 
 
† 
† 
† 
† 
32 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CHAPTER 4- DISCUSSION 
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The main finding of the present thesis is that bone health at the assessed sites was 
demonstrated to be lower in adult males with DMD compared to non-affected adult males and 
adult males with other variant forms of MD. Furthermore, TA ASCA was observed to be 
smaller in adult males with MD compared to those of non-affected adult males. 
Adult males affected by MD demonstrated lower grip strength compared to adult males 
unaffected by MD, with DMD participants unable to generate sufficient force to produce a 
reliable measure of grip strength. Furthermore, adult males affected by DMD demonstrated 
lower PASIPD scores compared with individuals with BeMD and lower BPAQ scores 
compared with all other individuals affected by MD. 
 
Subsequent to the observations of previous studies investigating BMD in MD individuals, 
adverse bone health in this population was anticipated. As demonstrated, studies involving 
populations of children and adolescents with MD have identified lower Z-scores in whole-body 
(Soderpalm et al, 2008); Lumbar spine (Bianchi et al, 2003; Hawker et al, 2005); and femoral 
BMD (Aparicio et al, 2002; Larson & Henderson, 2000). These studies have selected 
exclusively DMD populations with mean ages often in early childhood. Whilst this is justifiable 
due to the severity of this condition, the associated early loss of ambulation and the frequent 
use of long-term corticosteroid therapy to arrest muscle atrophy, it represents a narrow 
spectrum of MD individuals in both age and variety of impairment during advancement of age. 
Due to advances in cardiac medication, non-invasive ventilation and enhanced access to 
regular adult physiotherapy services, individuals with DMD are living longer than at any other 
point in history (Passamano et al, 2012) and as such, observation of adult individuals is 
important. This is especially true considering deleterious effects of immobility on bone health 
are anticipated to continue as an individual‟s functional impairments become more profound 
with symptom progression. With peak BMD achieved in early adulthood (Gilsanz et al, 1988), 
deterioration in bone density occurring after this point is likely to be more pronounced when 
combined with the effects of prolonged immobility and dependence upon powered mobility 
aids. 
 
Furthermore, while representing a continuum of less acute physical impairment, individuals 
with other variants of MD experience muscle atrophy, and loss of ambulation & function as 
symptoms of their condition. Successively, negative effects on bone health may also be 
expected in these individuals, as has been demonstrated in reductions in tibial and radial Z-
scores of BeMD and FSHD participants during this study.  
 
To date, Phillippe et al (2011), represents the only study to investigate BMD in adults with 
different forms of MD (inclusive of DMD). However, the use of a T-score – despite its clinical 
relevance - prevents a direct comparison with an age-matched reference group. Additionally, 
as discussed earlier, Z-scores are frequently used during observation of cohorts of individuals 
with long-term condition. With the use of Z-score as an outcome measure of BMD, an age-
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matched control group within the study is not critical to the relevance or significance of the 
data observed (Z-score being the comparison of BMD relative to an age-matched reference 
group). The data observed in this study is consistent with the reductions in BMD observed in 
adults with muscular dystrophy (Phillippe et al, 2011), albeit with differing selection of 
observation sites (lumbar spine and midshaft femur – Phillippe et al, 2011), with specific 
reductions in adult DMD individuals compared to other individuals with FSHD and LGMD.  
 
Phillippe et al, in their study, also do not include BeMD individuals as part of the participant 
cohort. The BeMD group in this study demonstrated lower T- and Z-scores for radius and tibia 
compared to other participants with MD and, while this was not statistically significant, it may 
prove to be clinically relevant particularly in a group of less ambulant individuals. Therefore, 
this study has progressed knowledge in this area due to its use of adult participants; its 
inclusion of participants with a variety of pathologies; and its use of a variety of outcome 
measures for BMD which may be more relevant for samples comprising individuals with long-
term conditions. 
 
The reduction in BMD in individuals affected by MD observed in this study is consistent with 
current theory of bone tissue maintenance and the influence of loss of bone loading on 
catabolic bone metabolism. As described by Frost‟s „mechanostat‟ theory (and subsequent 
Utah Paradigm) (Frost, 2003) sufficient mechanical stress acquired through bone loading is 
required to regulate osteoclast activity and prevent loss of bone density. The lower BMD 
observed in DMD individuals compared with unaffected controls and other ambulatory 
individuals with MD is consistent with the severity of the condition (earlier loss of ambulation; 
all participants wheelchair-dependent; reduced levels of physical activity). Reduced BMD was 
also observed in FSHD and BeMD individuals compared with unaffected controls, although 
this was only observed in the radius and not the tibia. This may be due to the continued bone 
loading of lower limbs in walking etc. (the majority of participants in LGMD, BeMD and FSHD 
cohorts were ambulant). 
 
TA ASCA was observed to be smaller in all participant groups affected by MD, with DMD 
individuals demonstrating the most significant reduction compared to unaffected controls. 
There were significant reductions in TA ASCA in DMD individuals compared with those 
participants affected by other variants of MD.  The TA has been used as an experimental site 
in previous studies investigating muscle size in individuals with long-term conditions (Kent-
Braun et al, 1997 – Multiple Sclerosis; Johansen et al, 2003 – Kidney Dialysis; Castro et al, 
1999 – Acute Spinal Cord Injury). TA is selected for its functional impact on ambulation (ankle 
dorsiflexion in gait) and its ease of analysis with clinical imaging equipment due to its 
superficial position and clear delineating osseous boundaries (Abe et al, 1994). The data 
reported in this study is similar to reductions in ASCA identified in individuals affected by 
disease states known to have associated reductions in physical activity and muscle strength 
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as reported by previous authors (Johansen et al, 2003; Kent-Braun et al, 1997). This 
presentation of reduced TA ASCA in individuals known to have mobility-limiting muscle 
conditions is consistent with current comprehension of muscle regulation. Models of disuse 
have been demonstrated in the sarcopenic elderly (Morley et al, 2011) and specifically 
functional impairment and physical disability have been identified as significant causes of 
reduction in muscle size and strength preservation (Janssen et al, 2002).  
 
Reduced ASCA in MD individuals compared with CTRL participants is anticipated due to the 
inflammatory damage associated with genetic protein defects within muscle tissue affected by 
MD (Kostek et al, 2012). Adipose and fibrous infiltrations replace contractile elements of 
muscle tissue (Wang et al, 2011) leading to gross loss of muscle power output and 
accelerated muscle fatigue on sustained contraction as well as promoting catabolic muscle 
metabolism in the presence of chronic elevation of inflammatory markers (IL6) (Haddad et al, 
2005). Reduced gross muscle strength proliferates an environment of muscle disuse, 
ultimately leading to clinical presentations of muscle weakness (e.g. TA weakness in 
individuals with FSHD presenting as a clinical sign of foot drop (Tawil, 2008)). Consistent with 
reductions in muscle power which have been previously reported, the present data observes 
lower handgrip strength from adult males with MD, compared to unaffected male controls.  
Reduced ASCA and grip strength in DMD individuals compared with other variants of MD is 
consistent with an increased severity of clinical presentation; including early loss of 
ambulation and dependence upon powered mobility aids in DMD individuals. This provides an 
environment of muscle disuse much earlier than other MD participants in this study (of whom 
the majority remained ambulant at the time of observation). 
 
In this study, BeMD participants demonstrated significantly larger TA ASCA than other 
individuals affected by MD. This is unlikely to be explained by differences in physical activity 
as the highest proportion of non-ambulant individuals (excluding DMD) was observed in the 
BeMD cohort. Pseudohypertrophy of crural musculature has been documented previously in 
BeMD individuals (Bradley et al, 2004). However, due to the imaging used in this study it is 
not possible to discount non-contractile elements of a muscle complex from the overall ASCA 
and as such the effects of these fibrous infiltrates on gross muscle ASCA cannot be 
estimated.  
 
Grip strength was significantly reduced in all MD participants compared to CTRL (BeMD -
51.2%; FSHD -46.3%; LGMD -49.9%), with those affected by DMD further significantly 
reduced compared with other MD participants. Due to the nature of the dynamometer 
equipment used, a minimum threshold of force was required to overcome inertia, the 
resistance of the machine, and generate a measurable outcome. While some DMD 
individuals participating in the trial maintain hand function sufficient to write, operate a 
computer/wheelchair joystick etc., they lacked the strength to overcome this threshold and as 
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such were unable to generate a reading of grip strength. A highly sensitive dynamometer 
would mitigate this issue however, due to clinical presentation and the results presented in 
this study, it is extremely unlikely that DMD individuals would achieve a generation of force 
comparable to other participants.  
 
Physical activity was significantly reduced in individuals with DMD compared to other MD 
participants when assessed using the BPAQ (developed by Weeks & Beck, 2008) and lower 
compared to BeMD individuals using the PASIPD score (developed by Washburn et al, 2002). 
There are key differences between the BPAQ and the PASIPD score which may affect the 
outcomes of these results. Firstly, the BPAQ takes into account historical, as well as current, 
reports of physical activity – this is not the case with the PASIPD. As MD presents as a 
progressive condition, historical reports of physical activity during childhood tended to be 
higher than current reports of activity within the last 12 months. As such the BPAQ captured 
data relevant specifically to bone health that the PASIPD did not and this may explain the 
higher intergroup mean difference.  
 
It is also worthy of consideration that individuals taking part in this study were undergoing 
regular physiotherapy. Regular, on-going physiotherapy is currently unavailable to individuals 
with MD through NHS services in the UK - where a patchwork of services prevails. This 
ranges from no intervention; to annual contact with a specialist therapist at a tertiary centre; to 
sporadic contact with a generic or neurological therapy service offering short-term manual 
therapy, exercise and advice; to on-going therapy (as part of home exercise programs 
administered by carers or relatives, or through private/voluntary sector services such as 
NMC). It may therefore be assumed that the participants in this study are not a sample 
applicable to the wider population of MD individuals. However, as previously discussed, the 
most significant period in life of accumulation of BMD and muscle mass is in childhood (pre-
15 years) (Rittweger, 2008) – the participants in this study are therefore unlikely to 
demonstrate gains in BMD or muscle mass through specific therapy, particularly if they 
experienced reduced levels of activity as children as a result of non-participation of sports etc. 
due to their condition. Furthermore, the physiotherapy provided by the NMC is of a broad-
spectrum; addressing multiple therapeutic problems such as pain, quality of life etc. and not 
specifically focused on strengthening exercise. Additionally, the input provided to individuals 
attending NMC often comprises low-intensity, low-load stretching, exercise and soft tissue 
therapy aimed at maintaining strength and function, which are likely to be of insignificant 
strain and frequency to stimulate positive changes in muscle size and BMD. Regardless, it is 
likely that due to the effects of the physiotherapy provided on a regular basis, the participants 
in this study may present less severely than similarly affected individuals who have not 
historically received regular therapy and supervised or accessible exercise. They may 
therefore represent a sample of individuals with a less profound presentation than individuals 
who do not regularly access physiotherapy and, as such, populations of MD individuals who 
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do not access regular physiotherapy are likely to be more severely affected by their condition 
in terms of muscle mass and BMD. 
 
Due to the variety of the conditions reported in this study, there were substantial ranges of 
BPAQ and PASIPD scores within all groups except DMD, even in a cohort of individuals 
receiving therapeutic input. It is therefore reasonable to suggest that larger sample sizes of 
individuals not clinically assessed as needing therapeutic input may yield more significant 
results when utilising the PASIPD. However, it should be noted that the population described 
in the present study represents the first adult male data in regards to muscle and bone from 
the dystrophic conditions, and represents a random selection of individuals (albeit a 
convenience sample) with different conditions.  
 
Conclusion 
Adult, male DMD individuals demonstrate significantly lower T- and Z-scores of bone health, 
TA ASCA and grip strength compared with unaffected male controls as well as other adult 
individuals with differing variants of MD.  Adult male individuals affected by BeMD, FSHD, and 
LGMD demonstrate significantly lower TA ASCA compared to unaffected male controls. All 
MD individuals demonstrated reduced grip strength compared to controls and DMD 
individuals reported significantly lower physical activity scores than other MD participants.  
 
Study Limitations 
Participants in the study were not age-matched. This is due to the participant sample 
available (clients attending the NMC in Winsford) representing a cross-section of individuals 
with MD. Furthermore, control participants were recruited from a student cohort, whereby 
mean age is low. This issue is partly ameliorated by the use of a Z-score outcome measure, 
which provides an age-matched reference value for BMD.  
 
Clinical Implications 
The present data is meaningful in the following ways. It suggests the negative impact of 
prolonged immobility on BMD (specifically bone unloading) and muscle. Given the effects of 
muscle atrophy on ambulation and balance, dependence upon powered mobili ty aids and 
reduced physical activity is common in individuals with MD. As prolonged periods of 
immobility or reduced physical activity are known to negatively impact upon bone and muscle 
tissue regulation, it is reasonable to envisage a multi-factorial, self-propagating feedback 
whereby reduced activity and limb loading (brought upon by gradual, unremitting muscle 
atrophy) produces further reductions in activity and limb loading until loss of ambulation, 
functional transfer etc. occurs. Implications on individual independence are significant, as 
reductions in function often necessitate external support from technology or persons. There 
are further connotations on fracture risk and incidence – with reductions in BMD leading to an 
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increased lifelong prevalence of fractures and associated medical treatment (including further 
risk and expense).  
 
Presently, there are no national guidelines advising healthcare professionals on the most 
adequate practice for the preservation of BMD and muscle mass in MD individuals, however, 
given the current theory of bone loading on preservation of BMD, efforts should be made to 
encourage and promote weight bearing in individuals with MD, particularly during childhood 
where the most significant accumulations of lifelong bone and muscle are made. This should 
be achieved through specific loading activities where suitable stress can be achieved as to 
satisfy the threshold for effective BMD regulation (such as ambulation). Furthermore, as BMD 
in particular is known to be regulated by a complex of factors, there may be implications other 
than loading exercise - such as diet (factors such as vitamin D and calcium uptake) – to 
consider in the clinical setting.  
 
Recommendations for future work 
It is the recommendation of this study that further study into this area is specifically required to 
establish the most efficacious method in preserving BMD and muscle size and strength in 
individuals with MD. Furthermore, it is of critical importance to assist healthcare professionals 
in providing evidence-based advice and therapy to prolong independence and function in 
those affected by MD. 
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